SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-006828
Filing Date
2017-11-09
Accepted
2017-11-09 15:37:34
Documents
36
Period of Report
2017-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110917p.htm 10-Q 272688
2 EXHIBIT 31.1 exh_311.htm EX-31.1 7808
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7913
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5275
  Complete submission text file 0001171843-17-006828.txt   1691972

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbit-20170930.xml EX-101.INS 263492
6 XBRL SCHEMA FILE xbit-20170930.xsd EX-101.SCH 18509
7 XBRL CALCULATION FILE xbit-20170930_cal.xml EX-101.CAL 20256
8 XBRL DEFINITION FILE xbit-20170930_def.xml EX-101.DEF 143232
9 XBRL LABEL FILE xbit-20170930_lab.xml EX-101.LAB 136136
10 XBRL PRESENTATION FILE xbit-20170930_pre.xml EX-101.PRE 154766
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 171190536
SIC: 2834 Pharmaceutical Preparations